.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Doobie Labs is stocked at 187 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Doobie Labs concentrated 72.91% of September 2026 sales in Flower while Pre-Roll accounted for 21.32% and Vapor Pens 5.77%, indicating a two-category core with a trailing adjunct. Year over year, Pre-Roll expanded 276.87% while Flower rose 14.51%, and month over month Pre-Roll climbed 21.21% as Flower edged down 0.25%; Vapor Pens contracted 8.98% month over month with no year-over-year read. With a category rank of 25 in Flower in New York and a portfolio tilt toward higher-ticket Flower at a $46.54 average versus $20.32 in Pre-Roll, the mix shift implies a gradual rebalancing toward faster-turning, lower-priced formats to sustain growth.
The surge in Pre-Roll share alongside a 24.45% decline in overall average price and a 21.21% month-over-month Pre-Roll gain suggests price elasticity is pulling volume toward value-access points, while a 0.25% month-over-month dip in Flower combined with a 14.51% year-over-year increase signals maturation of the flagship line. Given Doobie Labs’ 25th rank in Flower in New York and Vapor Pens shrinking 8.98% month over month, the trajectory indicates near-term positioning as a Flower-led brand that increasingly uses Pre-Roll scale to defend shelf presence and broaden entry points, rather than pushing deeper into higher-velocity vape competition.
Competitive Landscape
Doobie Labs sits at rank #25 in New York Flower for September 2026, unchanged year over year from #25, but up 4 positions versus June 2026’s #29, while still trailing its peak of #20 from December 2025; meanwhile, Find. climbed from #5 to #1 and Grassroots rose from #15 to #2 with a 150.3% year-over-year sales increase, indicating that leader-board mobility is occurring at the top even as Doobie Labs’ flat YoY rank and modest three-month gain signal a need to convert incremental momentum into share-taking against faster-advancing rivals.
Notable Products
Blue Lobster Pre-Roll (1g) delivered the standout move in September 2026 with an 89% month-over-month surge while holding the number 1 rank, contrasting with Blue Dream (3.5g) sliding 34% MoM to rank 5. Flower concentrations remain high with four of the top ten in Flower, yet Pre-Roll breadth is evident with ranks 1, 3, 6, 8, and 9, implying a demand skew toward ready-to-use formats even as legacy eighths retain shelf space. The Blue Lobster (3.5g) Flower SKU rose 32% MoM at rank 2 while Opal (3.5g) fell 20% MoM to rank 10, a split that indicates consumer trading up to branded strain equity while lower-tier Flower yields ground. The mix points to Doobie Labs leaning into Blue Lobster as a cross-format anchor and using Pre-Rolls to capture faster turns, which suggests portfolio priority toward format convenience over breadth expansion.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
